H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $22.00 and traded as high as $24.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares changing hands.
H. Lundbeck A/S Stock Performance
The company has a current ratio of 1.15, a quick ratio of 0.71 and a debt-to-equity ratio of 0.32. The stock’s 50 day moving average price is $22.00 and its two-hundred day moving average price is $22.00. The firm has a market capitalization of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68.
About H. Lundbeck A/S
H. Lundbeck A/S (OTCMKTS:HLUYY) is a Danish pharmaceutical company headquartered in Copenhagen that specializes in the research, development and commercialization of medicines for disorders of the central nervous system. Founded in 1915 by Hans Lundbeck, the company has built a long-standing focus on neuroscience, concentrating on therapies for psychiatric and neurological conditions rather than broader therapeutic areas.
Lundbeck’s primary activities include discovery and clinical development of novel compounds, regulatory filings, manufacturing and global commercialization of prescription medicines aimed at brain health.
Read More
- Five stocks we like better than H. Lundbeck A/S
- New Copper-Rich “Kraken” Zone Discovered
- Silver Is the New Oil—And the World’s Running Dry
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- Silver’s squeeze is tightening – opportunity forming
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
